The directive of the Jammu & Kashmir and Ladakh High Court to the Managing Director of the Jammu and Kashmir Medical Supplies Corporation Limited for ensuring the availability of life-saving drugs exposes a deeply troubling reality within the Union Territory’s healthcare administration. Hospitals are meant to be sanctuaries of healing, not places where patients are turned away for want of essential medicines. Yet, it is distressing that judicial intervention was needed to remind the authorities of such a basic obligation – to ensure an uninterrupted supply of life-saving drugs. The issue before the court was not an isolated case of supply chain delay; it reflected a systemic breakdown. The petitioners drew attention to the non-availability of vital anti-haemophilic drugs such as Factor VIII, Factor IX, and Von Willebrand factor-medicines that make the difference between life and death for haemophilia patients. According to submissions, around 51 patients remained untreated due to a lack of Factor IX. This is not merely administrative negligence; it borders on denial of the fundamental right to health.
JKMSCL was created as a dedicated body to manage the procurement and distribution of drugs, with the explicit purpose of eliminating shortages and ensuring transparency in the supply chain. That the system has failed so completely that the High Court must step in is both an indictment of the corporation and the wider Health Department. The silence and inaction of supervisory officials raise serious questions: are lapses being overlooked, or is there a deeper culture of complacency and indifference? Equally alarming is that the problem surfaced only because vigilant citizens approached the judiciary. Had civil society not acted, the suffering of patients might have remained buried under bureaucratic apathy. In an age of digital monitoring and real-time data, it is inexcusable that authorities remained unaware of or ignored the shortage. Access to medicines cannot depend on privilege or private insurance. For poor patients, the absence of a single drug can mean the end of life itself. The Government must now go beyond compliance reports. It must establish a real-time tracking mechanism for critical drug stocks, fix accountability for failures, and ensure that every hospital-from tertiary institutions to rural health centres-maintains a full inventory of life-saving drugs.
The post Ensuring Life Saving Drugs appeared first on Daily Excelsior.